ArticleOncoimmunology
p38 MAPK differentially controls NK activating ligands at transcriptional and post-transcriptional level on multiple myeloma cells.
Alessandra Soriani et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
23 papers cite it
cites it